Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2021-03-12 16:20:20
Reporting Period:
Accepted Time:
2021-03-12 16:20:20
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1104506 Insmed Inc INSM Pharmaceutical Preparations (2834) 541972729
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1740947 John Soriano 700 Us Highway 202/206
Bridgewater NJ 08807
Chief Compliance Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-11 23,717 $30.86 53,490 No 4 M Direct
Common Stock Disposition 2021-03-11 23,717 $40.00 29,773 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-03-11 23,717 $0.00 23,717 $30.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,550 2028-01-22 No 4 M Direct
  1. This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.01 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  2. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.